1,5-Anhydroglucitol attenuates cytokine release and protects mice with type 2 diabetes from inflammatory reactions.

Meng, X; Tancharoen, S; Kawahara, K-I; Nawa, Y; Taniguchi, S; Hashiguchi, T; Maruyama, I

Meng, X; Tancharoen, S; Kawahara, K-I; Nawa, Y; Taniguchi, S; Hashiguchi, T; Maruyama, I.

Affiliation

Meng X; Department of Laboratory and Vascular Medicine Cardiovascular and Respiratory Disorders Advanced Therapeutics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

Int J Immunopathol Pharmacol ; 23(1): 105-19, 2010.

Article in En | MEDLINE | ID: mdl-20377999

Subject(s)

Anti-Inflammatory Agents/pharmacology; Cytokines/antagonists & inhibitors; Deoxyglucose/pharmacology; Diabetes Mellitus, Type 2/immunology; Animals; Blood Glucose/analysis; Cell Line; Cytokines/biosynthesis; DNA/metabolism; Deoxyglucose/blood; Macrophages, Alveolar/drug effects; Male; Mice; NF-kappa B/antagonists & inhibitors; NF-kappa B/metabolism; Nitric Oxide Synthase Type II/antagonists & inhibitors; Nitric Oxide Synthase Type II/biosynthesis; Phosphorylation; Proto-Oncogene Proteins c-akt/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cytokines / Deoxyglucose / Diabetes Mellitus, Type 2 / Anti-Inflammatory Agents Limits: Animals Language: En Journal: Int J Immunopathol Pharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / PATOLOGIA Year: 2010 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links